Charles River Laboratories Return on Investment 2010-2024 | CRL

Current and historical return on investment (ROI) values for Charles River Laboratories (CRL) over the last 10 years.
Charles River Laboratories ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-06-30 $0.56B $6.14B 9.19%
2024-03-31 $0.58B $6.31B 9.47%
2023-12-31 $0.62B $6.25B 10.36%
2023-09-30 $0.65B $5.83B 11.14%
2023-06-30 $0.65B $5.94B 11.24%
2023-03-31 $0.67B $5.86B 11.77%
2022-12-31 $0.65B $5.69B 11.73%
2022-09-30 $0.66B $5.57B 12.16%
2022-06-30 $0.67B $5.65B 12.39%
2022-03-31 $0.62B $5.29B 11.81%
2021-12-31 $0.59B $5.20B 11.84%
2021-09-30 $0.55B $5.33B 11.63%
2021-06-30 $0.52B $5.05B 12.07%
2021-03-31 $0.46B $4.39B 11.38%
2020-12-31 $0.43B $4.05B 10.92%
2020-09-30 $0.41B $3.87B 10.80%
2020-06-30 $0.37B $3.96B 10.05%
2020-03-31 $0.38B $3.98B 10.45%
2019-12-31 $0.35B $3.49B 10.55%
2019-09-30 $0.35B $3.42B 10.77%
2019-06-30 $0.34B $3.50B 10.92%
2019-03-31 $0.33B $2.94B 11.30%
2018-12-31 $0.33B $2.96B 11.91%
2018-09-30 $0.29B $2.91B 11.31%
2018-06-30 $0.28B $2.98B 11.75%
2018-03-31 $0.29B $2.27B 13.20%
2017-12-31 $0.29B $2.16B 13.64%
2017-09-30 $0.30B $2.18B 14.11%
2017-06-30 $0.28B $2.08B 13.52%
2017-03-31 $0.26B $2.05B 12.24%
2016-12-31 $0.24B $2.05B 11.93%
2016-09-30 $0.22B $2.11B 11.76%
2016-06-30 $0.22B $2.17B 12.49%
2016-03-31 $0.21B $1.63B 13.78%
2015-12-31 $0.21B $1.58B 13.71%
2015-09-30 $0.20B $1.54B 13.35%
2015-06-30 $0.19B $1.46B 12.99%
2015-03-31 $0.18B $1.42B 12.65%
2014-12-31 $0.18B $1.42B 12.68%
2014-09-30 $0.16B $1.43B 11.81%
2014-06-30 $0.16B $1.46B 11.76%
2014-03-31 $0.15B $1.31B 11.57%
2013-12-31 $0.15B $1.29B 12.19%
2013-09-30 $0.16B $1.28B 13.41%
2013-06-30 $0.16B $1.27B 13.55%
2013-03-31 $0.17B $1.15B 14.54%
2012-12-31 $0.17B $1.13B 14.38%
2012-09-30 $0.17B $1.14B 14.66%
2012-06-30 $0.17B $1.12B 14.22%
2012-03-31 $0.18B $1.23B 13.96%
2011-12-31 $0.17B $1.23B 13.54%
2011-09-30 $-0.23B $1.26B -17.69%
2011-06-30 $-0.26B $1.32B -18.38%
2011-03-31 $-0.29B $1.33B -18.44%
2010-12-31 $-0.30B $1.36B -17.79%
2010-09-30 $0.10B $1.74B 5.62%
2010-06-30 $0.14B $1.80B 7.65%
2010-03-31 $0.16B $1.82B 8.85%
2009-12-31 $0.17B $1.83B 9.57%
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00